Higher FABP4 has been linked to metabolic diseases such as obesity and diabetes and higher FABP3 in the plasma has been linked to fatigue, physical activity intolerance, and muscle atrophy (Dowling et al., 2020; Furuhashi & Hotamisligil, 2008). This evidence concerns the gene FABP3 and metabolic disease.